CleanCap®

Search documents
Maravai LifeSciences (MRVI) Earnings Call Presentation
2025-06-19 09:44
NASDAQ: MRVI Investor Presentation June 2025 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may, from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, including, without lim ...
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
Globenewswire· 2025-05-21 20:22
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- This release corrects and replaces the version distributed earlier today at 16:05 ET. The original version inc ...
Maravai LifeSciencesReleases 2024 Sustainability Report
Globenewswire· 2025-05-21 20:05
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of lifescience reagents and services to ...
Maravai LifeSciences(MRVI) - 2025 Q1 - Earnings Call Presentation
2025-05-12 20:52
NASDAQ: MRVI Q1 2025 Financial Results May 12, 2025 Agenda | 01 | Welcome | Deb Hart, Head of Investor Relations | | --- | --- | --- | | 02 | Business Highlights | Trey Martin, Chief Executive Officer | | 03 | Financial Results | Kevin Herde, Chief Financial Officer | | | & Guidance | | | 04 | Q&A Session | Trey Martin, Chief Executive Officer Kevin Herde, Chief Financial Officer | | | | Becky Buzzeo, Chief Commercial Officer | © 2025 Maravai LifeSciences 2 Forward Looking Statements and Use of Non-GAAP Fin ...